y 27632 has been researched along with ginsenosides in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (ginsenosides) | Trials (ginsenosides) | Recent Studies (post-2010) (ginsenosides) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 4,821 | 61 | 3,179 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, X; Cui, YC; Fan, JY; Han, JY; He, K; Hu, BH; Li, Q; Liu, YY; Mao, XW; Pan, CS; Sun, K; Yan, L | 1 |
1 other study(ies) available for y 27632 and ginsenosides
Article | Year |
---|---|
ROCK-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Actins; Adenosine Triphosphate; Amides; Animals; Apoptosis; Cardiotonic Agents; Cell Culture Techniques; Cell Hypoxia; Enzyme Inhibitors; Ginsenosides; Male; Mitochondria, Heart; Myocardial Reperfusion Injury; Myofibrils; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases | 2014 |